Literature DB >> 8494050

Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

D J Law1, J G Tidball.   

Abstract

The myotendinous junction (MTJ) is the major site of force transmission from myofibrils across the muscle cell membrane to the extracellular matrix. The MTJ is thus an appropriate model system in which to test the hypothesis that dystrophin, the gene product absent in Duchenne muscular dystrophy, functions as a structural link between the muscle cytoskeleton and the cell membrane. We studied changes in MTJ structure in dystrophin-deficient mdx mice during periods of growth and aging that spanned prenecrotic, necrotic, and regenerative phases of postnatal muscle development in mdx mice. Prenecrotic animals were found to exhibit structural defects at MTJs that were similar to those described previously in animals at the peak of necrosis, including a reduction in lateral associations between thin filaments and the MTJ membrane. These defects therefore occur before necrosis and may be directly related to the absence of dystrophin. Observations of regenerating and fully regenerated MTJs in adult animals show that the defects are still present, indicating that normal thin filament-membrane associations are never formed in dystrophin-deficient muscle. However, in prenecrotic as well as regenerated adult mdx muscle, the MTJ membrane is only slightly less folded than in age-matched controls. This indicates that mdx muscle possesses some dystrophin-independent mechanism that allows for the initial formation of MTJs, despite the absence of dystrophin. The presence of the defect in normal, lateral, thin filament-membrane associations in mdx muscle, regardless of age, supports the hypothesis that dystrophin functions as a structural link between thin filaments and the membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494050      PMCID: PMC1886922     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Localization of paxillin, a focal adhesion protein, to smooth muscle dense plaques, and the myotendinous and neuromuscular junctions of skeletal muscle.

Authors:  C E Turner; N Kramarcy; R Sealock; K Burridge
Journal:  Exp Cell Res       Date:  1991-02       Impact factor: 3.905

2.  Immunocytochemical study of dystrophin at the myotendinous junction.

Authors:  C E Samitt; E Bonilla
Journal:  Muscle Nerve       Date:  1990-06       Impact factor: 3.217

3.  Structural changes at the myogenic cell surface during the formation of myotendinous junctions.

Authors:  J G Tidball; C Lin
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

4.  Structural domains of the muscle-tendon junction. 1. The internal lamina and the connecting domain.

Authors:  J A Trotter; S Eberhard; A Samora
Journal:  Anat Rec       Date:  1983-12

5.  Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions.

Authors:  B Weller; G Karpati; S Carpenter
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

6.  A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence.

Authors:  F Pons; N Augier; J O Léger; A Robert; F M Tomé; M Fardeau; T Voit; L V Nicholson; D Mornet; J J Léger
Journal:  FEBS Lett       Date:  1991-04-22       Impact factor: 4.124

7.  Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions.

Authors:  J G Tidball; D J Law
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Association of dystrophin and an integral membrane glycoprotein.

Authors:  K P Campbell; S D Kahl
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

9.  Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy.

Authors:  M J Cullen; E Jaros
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling.

Authors:  M J Cullen; J Walsh; L V Nicholson; J B Harris
Journal:  Proc R Soc Lond B Biol Sci       Date:  1990-05-22
View more
  16 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F.

Authors:  Derek J Milner; Stephen J Kaufman
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo.

Authors:  John C W Hildyard; Abbe H Crawford; Faye Rawson; Dominique O Riddell; Rachel C M Harron; Richard J Piercy
Journal:  Wellcome Open Res       Date:  2020-07-20

4.  The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice.

Authors:  Chady H Hakim; Robert W Grange; Dongsheng Duan
Journal:  J Appl Physiol (1985)       Date:  2011-03-17

5.  Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice.

Authors:  Dean J Burkin; Gregory Q Wallace; Derek J Milner; Eric J Chaney; James A Mulligan; Stephen J Kaufman
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 6.  Other model organisms for sarcomeric muscle diseases.

Authors:  John Sparrow; Simon M Hughes; Laurent Segalat
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin.

Authors:  Glen B Banks; Ariana C Combs; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2008-09-16       Impact factor: 6.150

8.  New insights on contraction efficiency in patients with Duchenne muscular dystrophy.

Authors:  Lilian Lacourpaille; François Hug; Arnaud Guével; Yann Péréon; Armelle Magot; Jean-Yves Hogrel; Antoine Nordez
Journal:  J Appl Physiol (1985)       Date:  2014-08-07

9.  Morphogenesis of rat myotendinous junction.

Authors:  Davide Curzi; Patrizia Ambrogini; Elisabetta Falcieri; Sabrina Burattini
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

10.  Myotendinous junction defects and reduced force transmission in mice that lack alpha7 integrin and utrophin.

Authors:  Jennifer V Welser; Jachinta E Rooney; Nicolette C Cohen; Praveen B Gurpur; Cherie A Singer; Rebecca A Evans; Bryan A Haines; Dean J Burkin
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.